- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Redhill Biopharma Ltd+ Add to Watchlist
RDHL:US14.6900 USD 0.1200 0.82%
As of 20:10:00 ET on 04/17/2015.
Company Profile for Redhill Biopharma Ltd (RDHL)
Redhill Biopharma Ltd focuses primarily on the development and acquisition of therapeutic candidates acquired through asset purchases or in-licensing. The Company acquires, in-licenses and develops patent-protected new formulations and combinations of existing drugs in advanced stages of development.
Redhill Biopharma Ltd
Key Executives for Redhill Biopharma Ltd (RDHL)
|Dror Ben-AsherChairman/CEO||Ori ShiloDpty CEO:Finance & Operations|
|Uri Hananel AharonChief Accounting Officer||Guy GoldbergChief Business Officer|
|Ira N KalfusChief Medical Officer||Gilead RadaySenior VP:Product & Corporate Development|
|Adi FrishSenior VP:Business Dev||Reza FathiSenior VP:Research & Development|